Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune-inflammatory responses in diabetic Apoe (-/-) mice

E. Di Marco, S. P. Gray, P. Chew, C. Koulis, A. Ziegler, C. Szyndralewiez, R. M. Touyz, H. H. H. W. Schmidt, M. E. Cooper, R. Slattery, K. A. Jandeleit-Dahm

Research output: Contribution to journalArticleAcademicpeer-review

22 Citations (Scopus)
Original languageEnglish
Pages (from-to)633-642
JournalDiabetologia
Volume57
Issue number3
DOIs
Publication statusPublished - Mar 2014

Keywords

  • Atherosclerosis
  • Diabetes
  • Immune system
  • Inflammation
  • NOX

Cite this

Di Marco, E., Gray, S. P., Chew, P., Koulis, C., Ziegler, A., Szyndralewiez, C., Touyz, R. M., Schmidt, H. H. H. W., Cooper, M. E., Slattery, R., & Jandeleit-Dahm, K. A. (2014). Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune-inflammatory responses in diabetic Apoe (-/-) mice. Diabetologia, 57(3), 633-642. https://doi.org/10.1007/s00125-013-3118-3